Crispr Therapeutics shares owned by Mirae Asset Global Etfs Holdings
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Mirae Asset Global Etfs Holdings
from 13F filings
Historical chart of Mirae Asset Global Etfs Holdings investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Mirae Asset Global Etfs Holdings
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.4M | 99k | 64.81 |
| 2025-06-30 | $5.1M | 105k | 48.64 |
| 2025-03-31 | $2.6M | 75k | 34.03 |
| 2024-12-31 | $3.1M | 80k | 39.36 |
| 2024-09-30 | $3.1M | 66k | 46.98 |
| 2024-06-30 | $4.3M | 77k | 55.38 |
More positions owned by Mirae Asset Global Etfs Holdings
View all positions for Mirae Asset Global Etfs Holdings